Skip to content

Startup & venture capital news

Metabolize raises USD 3.2m to develop metabolic health products

Astanor leads seed financing for the San Francisco company

By /

LinkedInX
Metabolize: Metabolize raises USD 3.2m to develop metabolic health products
SOSV founder interview; photographer not stated

Metabolize announced USD 3.2 million in seed financing on 15 October 2026, led by Astanor. Founded by Dr Morris Laster and Gideon Meir, the San Francisco company is commercializing licensed research originating at Stanford Medicine. Its Precision Metabolite Technology focuses on naturally occurring compounds with defined biological roles. The capital will support product development, validation, manufacturing and commercialization. Maia Ventures, LongGame Venture and SOSV also participated. Metabolize plans to introduce its first consumer product, NATLEAN, in January 2027, targeting people transitioning off GLP-1 therapies. That intended use is a development objective, not evidence that the product has established clinical effectiveness.

Keep reading

More Funding

All stories